Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 3
Out of 5,147 analysts
139
Total ratings
67.35%
Success rate
154.85%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $211.91 | +3.82% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $98.31 | +6.81% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $210.64 | +30.55% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $9.05 | -0.55% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $76.33 | +53.28% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $319.38 | +20.55% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $121.38 | +27.70% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $79.71 | +0.36% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $22.74 | +93.49% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,366.69 | -19.51% | 8 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $289.12 | +0.30% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $9.83 | +123.80% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $75.36 | +12.79% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $49.80 | +6.37% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $46.92 | -25.40% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $23.05 | +4.12% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.68 | +138.10% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.42 | +23.97% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $208.04 | -31.74% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $93.90 | -65.92% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $134.46 | -14.47% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.61 | +333.84% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $521.11 | +24.73% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $16.25 | -44.62% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.33 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.72 | +597.67% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $6.55 | +816.03% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.50 | +411.11% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $178.49 | +118.50% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.15 | +471.43% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $503.51 | -60.28% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $29.21 | -17.84% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $14.68 | +206.54% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $128.73 | -45.62% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $178.81 | -32.89% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.58 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.11 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $8.46 | +550.12% | 1 | Jul 19, 2016 |
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $211.91
Upside: +3.82%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $98.31
Upside: +6.81%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $210.64
Upside: +30.55%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $9.05
Upside: -0.55%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $76.33
Upside: +53.28%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $319.38
Upside: +20.55%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $121.38
Upside: +27.70%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $79.71
Upside: +0.36%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $22.74
Upside: +93.49%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,366.69
Upside: -19.51%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $289.12
Upside: +0.30%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $9.83
Upside: +123.80%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $75.36
Upside: +12.79%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $49.80
Upside: +6.37%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $46.92
Upside: -25.40%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $23.05
Upside: +4.12%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.68
Upside: +138.10%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.42
Upside: +23.97%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $208.04
Upside: -31.74%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $93.90
Upside: -65.92%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $134.46
Upside: -14.47%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.61
Upside: +333.84%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $521.11
Upside: +24.73%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $16.25
Upside: -44.62%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.33
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.72
Upside: +597.67%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $6.55
Upside: +816.03%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.50
Upside: +411.11%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $178.49
Upside: +118.50%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.15
Upside: +471.43%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $503.51
Upside: -60.28%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $29.21
Upside: -17.84%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $14.68
Upside: +206.54%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $128.73
Upside: -45.62%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $178.81
Upside: -32.89%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.58
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $40.11
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $8.46
Upside: +550.12%